Clinical Trial Update: Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled alpha-1 antitrypsin for preventing bronchiolitis obliterans syndrome in lung transplant recipients, reporting on saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• inhaled alpha-1 antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Lung Transplantation, Bronchiolitis Obliterable Syndrome | Phase 2 | Status: UNKNOWN